Metoprolol Succinate Tablet, Film Coated, Extended Release
Product Images NDC 67296-2301

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 67296-2301). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container25mg100 (Container25mg100)

Packaging label for Metoprolol Succinate Extended-Release Tablets, USP 25 mg, 100 count. The label includes the NDC 72603-142-01 and indicates the medication is Rx only. Manufactured by Dr. Reddy's Laboratories Limited in India for Northstar Rx LLC, Memphis, TN. Storage instructions and warning to keep out of reach of children are included, along with a barcode and GTIN 00372603142013.*

FDA Label Image

Container50mg100 (Container50mg100)

Packaging label for Metoprolol Succinate Extended-Release Tablets USP, 50 mg strength. The film-coated tablets are supplied in a package containing 100 tablets. The label indicates the product is manufactured by Dr. Reddy's Laboratories Limited and labeled for Northstar Rx LLC, Memphis, TN. The label includes storage instructions and a barcode.*

FDA Label Image

Figure (Figure)

A forest plot showing subgroup results from the MERIT-HF study. It compares relative risk and 95% confidence intervals for metoprolol succinate extended-release tablets versus placebo for three outcomes: total mortality, total mortality or all-cause hospitalization (time to first event), and total mortality or hospitalization for heart failure (time to first event). Subgroups include demographic and clinical factors such as NYHA class, ejection fraction, ischemic etiology, sex, race, myocardial infarction history, diabetes, hypertension, and heart rate.*

FDA Label Image

Structure (Structure)

Chemical structure of metoprolol succinate showing the metoprolol moiety on the left and the succinate component on the right, indicating the extended-release salt form of the drug.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.